GABRP sustains the stemness of triple-negative breast cancer cells through EGFR signaling
Xi‐Yin Li, Hairui Wang, Xing Yang, Xiaoqi Wang, Lina Zhao, Li‐Wei Zou, Qin Yang, Zongliu Hou, Jing Tan, Honglei Zhang, Jianyun Nie, Baowei Jiao
Topics & Concepts
GefitinibTriple-negative breast cancerEpidermal growth factor receptorCancer researchEGFR inhibitorsMedicinePaclitaxelBreast cancerCancer stem cellTargeted therapyCancerOncologyPharmacologyInternal medicineLung Cancer Treatments and MutationsHER2/EGFR in Cancer ResearchCancer therapeutics and mechanisms